Beedan 70 mg Tablet

Beedan 70 mg Tablet contains dasatinib, a targeted anticancer medicine used to treat certain blood cancers. It is an oral tablet containing 70 mg of dasatinib and is taken as prescribed by a specialist. It is mainly used for Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia.

BUY NOW

Dasatinib is a tyrosine kinase inhibitor that blocks abnormal BCR-ABL signaling involved in the growth of certain leukemia cells. By inhibiting these proteins, it helps slow the multiplication and survival of abnormal blood cells. Beedan may be prescribed when specific leukemia types require targeted treatment based on the patient’s clinical condition. Regular medical monitoring is important during therapy to assess blood counts, treatment response, and potential adverse effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 70 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 Tablets
Manufacturer/Marketer Adley Formulations

Product Also Known As

Beedan 70 mg Tablet, Dasatinib 70 mg Tablet, Beedan Dasatinib Tablet, Dasatinib Anticancer Tablet, Beedan Leukemia Treatment Tablet, Dasatinib Tyrosine Kinase Inhibitor Tablet